Untargeted metabolomic profiling in a patient with glycogen storage disease <scp>Ib</scp> receiving empagliflozin treatment-Reference-Cited by-同舟云学术

Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment

Published:2022-05-22 Issue:4 Volume:63 Page:309-315
ISSN:2192-8312
Container-title:JIMD Reports
language:en
Short-container-title:JIMD Reports

Author:

Tallis Eran¹,Karsenty Cecile L.²³,Grimes Amanda B.²³,Karam Lina B.⁴,Elsea Sarah H.¹⁵,Sutton Vernon Reed¹⁵,Rawls‐Castillo Brandy L.¹,Liu Ning¹⁵,Soler‐Alfonso Claudia¹^ORCID

Affiliation:

1. Department of Molecular and Human Genetics Baylor College of Medicine Houston Texas USA

2. Department of Pediatrics Baylor College of Medicine Houston Texas USA

3. Texas Children's Cancer and Hematology Centers Houston Texas USA

4. Department of Pediatrics‐Gastroenterology Baylor College of Medicine Houston Texas USA

5. Baylor Genetics Houston Texas USA

Publisher

Wiley

Subject

Biochemistry, Genetics and Molecular Biology (miscellaneous),Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmd2.12304

Reference26 articles.

1. Glycogen storage disease type Ib: role of glucose‐6‐phosphate transporter in cell metabolism and function

2. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes

3. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: Results of the European Study on Glycogen Storage Disease Type I

4. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b)

5. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut Dysbiosis Drives Inflammatory Bowel Disease Through the CCL4L2‐VSIR Axis in Glycogen Storage Disease;Advanced Science;2024-06-18

2. Case report: The success of empagliflozin therapy for glycogen storage disease type 1b;Frontiers in Endocrinology;2024-06-11

3. Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review;Pediatric Drugs;2024-04-18

4. Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop;Molecular Genetics and Metabolism;2024-03

5. Glycogen storage disease type Ib: modern understanding of the pathogenesis of neutropenia and prospects for its treatment with empagliflozin;Pediatric pharmacology;2023-11-17